FTO and breast carcinoma: In other words, elevated YTHDF2 expression in FTO silencing breast cancer cells could not inverse the increasing of BNIP3 mRNA expression, indicating the presence of alternative mechanism to stabilize m6A-modified BNIP3 mRNA.